Loading stock data…
Sinovac Biotech, Ltd. (SVA)
$6.47
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sinovac Biotech Ltd. is trading at $6.47. Wall Street consensus targets $3.52 (6 analysts), implying a -45.6% move over the next 12 months. The stock is currently , remaining 0.0% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 100 is overbought against a weak tape. The Whystock Score of 0/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side targets imply -45.6% downside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 100 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q2 2024 |
|---|---|
| Total Revenue | — |
| Gross Profit | — |
| Operating Income | — |
| Net Income | — |
Peer Comparison
Fundamentals
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
6.66
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
850.08%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
0
Recent News
OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s ability to support its valuation.
Stocks to watch this week: Shell, TSMC, Levi Strauss, Vistry and Jet2
Earnings preview of key companies reporting in the coming week and what to look out for.